Related search

Underuse of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation in Italy

Internal and Emergency Medicine
Internal MedicineEmergency Medicine
2007English

Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation

JAMA network open
Medicine
2020English

Prevention of Cardiovascular Outcomes in Diabetic Patients With Atrial Fibrillation: Direct Oral Anticoagulants or Warfarin?

Clinical pharmacology and therapy
2019English

Cost-Effectiveness of New Oral Anticoagulants for Patients With Atrial Fibrillation – A Decision Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Safety and Efficacy of Direct Oral Anticoagulants for Atrial Fibrillation in Patients With Renal Impairment

Pharmacy
2020English

Characteristics and Outcomes in Patients With Atrial Fibrillation Receiving Direct Oral Anticoagulants in Off-Label Doses

BMC Cardiovascular Disorders
Cardiovascular MedicineCardiology
2020English

Effect and Risk of Novel Oral Anticoagulants Versus Warfarin in Patients With Non-Valvular Atrial Fibrillation

Journal of Cardiology
Cardiovascular MedicineCardiology
2017English

Periprocedural Management of New Oral Anticoagulants in Patients Undergoing Atrial Fibrillation Ablation

Circulation
Cardiovascular MedicinePhysiologyCardiology
2014English

The Therapy With Oral Anticoagulants in Patients With Atrial Fibrillation in Outpatient and Hospital Settings (Data From RECVASA Registries)

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy